TEXAS CAPITAL BANCSHARES INC/TX Debt Disclosure
| (dollars in thousands) | Federal Funds Purchased | Customer Repurchase Agreements | FHLB Borrowings | |||||||||||||||||
| December 31, 2025 | ||||||||||||||||||||
| Amount outstanding at year-end | $ | 30,000 | $ | — | $ | 300,000 | ||||||||||||||
| Interest rate at year-end | 3.74 | % | — | % | 3.72 | % | ||||||||||||||
| Average balance outstanding during the year | $ | 39,691 | $ | — | $ | 288,808 | ||||||||||||||
| Weighted-average interest rate during the year | 4.51 | % | — | % | 4.35 | % | ||||||||||||||
| Maximum month-end outstanding during the year | $ | 588,000 | $ | — | $ | 1,400,000 | ||||||||||||||
| December 31, 2024 | ||||||||||||||||||||
| Amount outstanding at year-end | $ | — | $ | — | $ | 885,000 | ||||||||||||||
| Interest rate at year-end | — | % | — | % | 4.38 | % | ||||||||||||||
| Average balance outstanding during the year | $ | 16 | $ | — | $ | 933,880 | ||||||||||||||
| Weighted-average interest rate during the year | 17.82 | % | — | % | 5.35 | % | ||||||||||||||
| Maximum month-end outstanding during the year | $ | — | $ | — | $ | 1,675,000 | ||||||||||||||
| (in thousands) | December 31, 2025 | December 31, 2024 | |||||||||
| FHLB borrowing capacity relating to loans and pledged securities | $ | 2,570,596 | $ | 4,664,703 | |||||||
| FHLB borrowing capacity relating to unencumbered securities | 4,594,553 | 4,189,993 | |||||||||
| Total FHLB borrowing capacity(1) | $ | 7,165,149 | $ | 8,854,696 | |||||||
| Unused federal funds lines available from commercial banks | $ | 1,520,000 | $ | 1,370,000 | |||||||
| Unused Federal Reserve borrowings capacity | $ | 9,174,238 | $ | 5,436,652 | |||||||
| Unused revolving line of credit(2) | $ | 75,000 | $ | 75,000 | |||||||
| (in thousands) | December 31, 2025 | December 31, 2024 | ||||||||||||
Bank-issued 5.25% fixed rate subordinated notes due 2026 | $ | 134,509 | $ | 174,717 | ||||||||||
Company-issued 4.00% fixed rate subordinated notes due 2031 | 372,660 | 372,223 | ||||||||||||
| Trust preferred floating rate subordinated debentures due 2032 to 2036 | 113,406 | 113,406 | ||||||||||||
| Total long-term debt | $ | 620,575 | $ | 660,346 | ||||||||||
| (dollars in thousands) | Texas Capital Statutory Trust I | Texas Capital Statutory Trust II | Texas Capital Statutory Trust III | Texas Capital Statutory Trust IV | Texas Capital Statutory Trust V | ||||||||||||||||||||||||
| Date issued | November 19, 2002 | April 10, 2003 | October 6, 2005 | April 28, 2006 | September 29, 2006 | ||||||||||||||||||||||||
| Trust preferred securities issued | $10,310 | $10,310 | $25,774 | $25,774 | $41,238 | ||||||||||||||||||||||||
| Floating or fixed rate securities | Floating | Floating | Floating | Floating | Floating | ||||||||||||||||||||||||
| Interest rate on subordinated debentures | 3 month SOFR + 3.61% | 3 month SOFR + 3.51% | 3 month SOFR + 1.77% | 3 month SOFR + 1.86% | 3 month SOFR + 1.97% | ||||||||||||||||||||||||
| Maturity date | November 2032 | April 2033 | December 2035 | June 2036 | December 2036 | ||||||||||||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 10, 2026 | Showing above |
| 2024 | Feb 11, 2025 | |
| 2023 | Feb 13, 2024 | |
| 2022 | Feb 9, 2023 | |
| 2021 | Feb 9, 2022 | |
| 2020 | Feb 9, 2021 | |
| 2019 | Feb 12, 2020 | |
| 2018 | Feb 14, 2019 | |
| 2017 | Feb 14, 2018 | |
| 2016 | Feb 17, 2017 | |
| 2015 | Feb 18, 2016 | |
About Debt Disclosures
Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.
Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.